NHS Industries Ltd. and Cannabis Science, Inc. have mutually agreed to terminate the previously announced Joint Venture Agreement of August 28, 2019. During further review of numerous proposed logistics, both parties, NHS and Cannabis Science, agreed that anticipated synergies that would create a mutually beneficial environment to further the joint venture were not present.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.015 CAD | 0.00% |
|
0.00% | 0.00% |
27/05 | Ultra Brands Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
26/04 | Ultra Brands Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
0.00% | 202K | |
-4.63% | 271B | |
-7.99% | 89.39B | |
-12.60% | 39.25B | |
-1.49% | 36.23B | |
-1.82% | 37.02B | |
-15.99% | 30B | |
-4.87% | 29.23B | |
+4.15% | 23.68B | |
-15.73% | 20.99B |
- Stock Market
- Equities
- ULTA Stock
- News Ultra Brands Ltd.
- NHS Industries, Ltd. and Cannabis Science, Inc. Agree to Terminate the Previously Announced Joint Venture Agreement